Sanofi and Regeneron’s expected blockbuster RA drug, sarilumab received FDA CRL for manufacturing concerns
Posted on31 Oct 2016
Comments0
Sanofi and Regeneron Pharmaceuticals, Inc. announced the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Biologics... Read More
Allergan receives US FDA approval for Restasis Multidose for chronic dry eye
Allergan Introduces RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help... Read More
Case Study: Insignt on GSK’s cold and flu-tracking app – campaign to launch Theraflu ExpressMax Caplets
GSK consumar healthcare has introduced, the Cold and Flu Tracker app, where people can get updates on cold and flu activity at... Read More
Pfizer to market Biosimilar INFLECTRA® in US by December
Posted on19 Oct 2016
Comments0
Pfizer Inc. will begin shipment of INFLECTRA® (infliximab-dyyb)for injection, a biosimilar of REMICADE® (infliximab) to wholesalers in the United States (U.S.) in... Read More
Boehringer Ingelheim, Lupin signed co-marketing deal for Empagliflozin in Indian market
Posted on14 Oct 2016
Comments0
Boehringer Ingelheim and Lupin have entered into a partnership to co-market Empagliflozin used for treatment of type 2 diabetes in India. Under... Read More
Zydus to introduce immunosuppressant drug Grafalo in India with licensing deal with Switzerland-based global biopharmaceutical company Neovii
Zydus, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug... Read More
Intas Pharma to acquire Teva’s UK, Ireland generics businesses
Intas Pharmaceuticals Ltd agreed to buy Actavis UK Ltd and Actavis Ireland Ltd from Israeli generic drug maker Teva Pharmaceutical Industries Ltd... Read More